174 related articles for article (PubMed ID: 16395307)
21. Non-specific effect of naltrexone on ethanol consumption in social drinkers.
de Wit H; Svenson J; York A
Psychopharmacology (Berl); 1999 Sep; 146(1):33-41. PubMed ID: 10485962
[TBL] [Abstract][Full Text] [Related]
22. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS
Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
24. Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.
Krishnan-Sarin S; O'Malley SS; Franco N; Cavallo DA; Tetrault JM; Shi J; Gueorguieva R; Pittman B; Krystal JH
Neuropsychopharmacology; 2020 Jan; 45(2):319-326. PubMed ID: 31590179
[TBL] [Abstract][Full Text] [Related]
25. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
Ray LA; Hutchison KE
Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
[TBL] [Abstract][Full Text] [Related]
26. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
[TBL] [Abstract][Full Text] [Related]
27. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
McCaul ME; Wand GS; Rohde C; Lee SM
Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
[TBL] [Abstract][Full Text] [Related]
28. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.
Johnson BA; O'Malley SS; Ciraulo DA; Roache JD; Chambers RA; Sarid-Segal O; Couper D
J Clin Psychopharmacol; 2003 Jun; 23(3):281-93. PubMed ID: 12826990
[TBL] [Abstract][Full Text] [Related]
29. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC
Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331
[TBL] [Abstract][Full Text] [Related]
30. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking.
Hernandez-Avila CA; Song C; Kuo L; Tennen H; Armeli S; Kranzler HR
Alcohol Clin Exp Res; 2006 May; 30(5):860-5. PubMed ID: 16634855
[TBL] [Abstract][Full Text] [Related]
31. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
Rabben T; Skjelbred P; Oye I
J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
[TBL] [Abstract][Full Text] [Related]
32. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
[TBL] [Abstract][Full Text] [Related]
34. Effects of naltrexone on alcohol self-administration in heavy drinkers.
Davidson D; Palfai T; Bird C; Swift R
Alcohol Clin Exp Res; 1999 Feb; 23(2):195-203. PubMed ID: 10069545
[TBL] [Abstract][Full Text] [Related]
35. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
[TBL] [Abstract][Full Text] [Related]
36. Clinical and sensorimotor gating effects of ketamine in normals.
Duncan EJ; Madonick SH; Parwani A; Angrist B; Rajan R; Chakravorty S; Efferen TR; Szilagyi S; Stephanides M; Chappell PB; Gonzenbach S; Ko GN; Rotrosen JP
Neuropsychopharmacology; 2001 Jul; 25(1):72-83. PubMed ID: 11377920
[TBL] [Abstract][Full Text] [Related]
37. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R;
Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245
[TBL] [Abstract][Full Text] [Related]
38. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
39. Effects of the non-competitive NMDA receptor antagonist memantine on the volitional consumption of ethanol by alcohol-preferring rats.
Malpass GE; Williams HL; McMillen BA
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):435-44. PubMed ID: 20210793
[TBL] [Abstract][Full Text] [Related]
40. A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene.
Drobes DJ; Anton RF; Thomas SE; Voronin K
Neuropsychopharmacology; 2003 Apr; 28(4):755-64. PubMed ID: 12655322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
